Table 2 Overall survival and disease-free survival of 131 HCC patients by univariate analysis

OATP1B3

0.000

0.001

Low expression

78

5.3%

12.9%

High expression

53

18.8%

33.0%

Age (year)

0.933

0.590

 ≥ 50

56

9.4%

23.2%

 < 50

75

11.2%

19.8%

Sex

0.418

0.735

 Male

104

10.6%

20.0%

 Female

27

11.1%

25.9%

Tumor size

0.065

0.205

 ≥ 5 cm

88

7.8%

17.8%

 < 5 cm

43

15.0%

28.9%

TNM stage

0.000

0.000

 I, II

50

21.3%

32.9%

 III, IV

81

3.5%

13.8%

Tumor differentiation

0.452

0.076

 Well

9

13.0%

50.0%

 Moderate

101

10.5%

15.6%

 Poor

21

10.6%

36.1%

Serum AFP

0.045

0.037

 ≥ 20 ng/mL

89

7.3%

18.0%

 < 20 ng/mL

42

16.1%

28.0%

Invasion

0.016

0.026

 Yes

58

6.8%

14.8%

 No

73

13.5%

26.5%

HBsAg

0.386

0.434

 Positive

106

9.2%

20.5%

 Negative

25

17.1%

25.4%

Tumor number

0.147

0.371

 Single

87

12.2%

23.7%

 Multiple

44

7.1%

16.0%

Liver cirrhosis

0.682

0.972

 Yes

91

10.8%

21.7%

 No

40

10.5%

20.8%

Tumor capsule

0.513

0.785

 Yes

45

11.1%

23.6%

 No

86

0.99%

20.2%